Benefits of mRNA COVID-19 vaccines for Omicron outweigh risks regardless of age, sex, or comorbidities
The benefits of mRNA vaccines are much larger than the risks, for both the primary series and the booster doses, across all ages, sexes, and the presence or absence of comorbidities, even considering the reduced disease severity of the Omicron variant.

New Molecule

1 New

New Presentation

1 New

Markings
Shape
Form
Color 1
Color 2
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in